ProShares Ultra Nasdaq Biotechnology (BIB)

NASDAQ: BIB · Real-Time Price · USD

82.85

+0.31 (0.37%)

May 5, 2026, 4:00 PM EDT - Market closed

0.37% (1D)

Assets	$74.18M
Expense Ratio	95.00%
PE Ratio	n/a
Shares Out	930,000
Dividend (ttm)	$0.49
Dividend Yield	0.60%
Ex-Dividend Date	Mar 25, 2026
Payout Frequency	Quarterly
Payout Ratio	n/a

Volume	7,074
Open	83.88
Previous Close	82.54
Day's Range	81.43 - 83.88
52-Week Low	39.47
52-Week High	90.91
Beta	1.25
Holdings	263
Inception Date	Apr 8, 2010

About BIB

Fund Home Page

The ProShares Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ. BIB was launched on Apr 8, 2010 and is issued by ProShares.

Asset Class Equity

Category Trading--Leveraged Equity

Stock Exchange NASDAQ

Ticker Symbol BIB

ETF Provider ProShares

Index Tracked NASDAQ / Biotechnology

Top 10 Holdings

151.91% of assets

Name	Symbol	Weight
NASDAQ BIO INDEX SWAP BNP PARIBAS	n/a	35.22%
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA	n/a	29.56%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA	n/a	27.07%
NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL	n/a	20.27%
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE	n/a	16.90%
Gilead Sciences, Inc.	GILD	4.86%
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG	n/a	4.86%
Vertex Pharmaceuticals Incorporated	VRTX	4.72%
Amgen Inc.	AMGN	4.55%
Regeneron Pharmaceuticals, Inc.	REGN	3.90%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Mar 25, 2026	$0.00714	Mar 31, 2026
Dec 24, 2025	$0.13464	Dec 31, 2025
Sep 24, 2025	$0.18054	Sep 30, 2025
Jun 25, 2025	$0.17058	Jul 1, 2025
Mar 26, 2025	$0.13094	Apr 1, 2025
Dec 23, 2024	$0.39644	Dec 31, 2024

Full Dividend History

Performance

BIB had a total return of 75.60% in the past year, including dividends. Since the fund's inception, the average annual return has been 16.44%.